Does CANAKINUMAB Cause Terminal state? 116 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 116 reports of Terminal state have been filed in association with CANAKINUMAB (Ilaris). This represents 1.1% of all adverse event reports for CANAKINUMAB.
116
Reports of Terminal state with CANAKINUMAB
1.1%
of all CANAKINUMAB reports
53
Deaths
94
Hospitalizations
How Dangerous Is Terminal state From CANAKINUMAB?
Of the 116 reports, 53 (45.7%) resulted in death, 94 (81.0%) required hospitalization, and 112 (96.6%) were considered life-threatening.
Is Terminal state Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANAKINUMAB. However, 116 reports have been filed with the FAERS database.
What Other Side Effects Does CANAKINUMAB Cause?
Pyrexia (1,327)
Inappropriate schedule of drug administration (1,238)
Drug ineffective (1,078)
Inappropriate schedule of product administration (944)
Pain (858)
Condition aggravated (771)
Malaise (684)
Off label use (557)
Arthralgia (555)
Rash (505)
What Other Drugs Cause Terminal state?
LEUPROLIDE (700)
DENOSUMAB (563)
DARBEPOETIN ALFA (299)
CARBIDOPA\LEVODOPA (289)
ADALIMUMAB (253)
OCTREOTIDE (232)
ETANERCEPT (200)
RITUXIMAB (182)
ABATACEPT (181)
CLOZAPINE (180)
Which CANAKINUMAB Alternatives Have Lower Terminal state Risk?
CANAKINUMAB vs CANDESARTAN
CANAKINUMAB vs CANDESARTAN CILEXETIL
CANAKINUMAB vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANAKINUMAB vs CANGRELOR
CANAKINUMAB vs CANIS LUPUS FAMILIARIS SKIN